AMP Capital Investors Ltd reduced its position in USANA Health Sciences, Inc. (NYSE:USNA) by 60.9% during the 2nd quarter, HoldingsChannel reports. The fund owned 2,760 shares of the company’s stock after selling 4,300 shares during the quarter. AMP Capital Investors Ltd’s holdings in USANA Health Sciences were worth $318,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Robecosam AG purchased a new position in USANA Health Sciences during the first quarter valued at approximately $126,000. SG Americas Securities LLC purchased a new position in USANA Health Sciences during the first quarter valued at approximately $137,000. Susquehanna Fundamental Investments LLC purchased a new position in USANA Health Sciences during the first quarter valued at approximately $206,000. Element Capital Management LLC purchased a new position in USANA Health Sciences during the first quarter valued at approximately $211,000. Finally, CAPROCK Group Inc. purchased a new position in USANA Health Sciences during the second quarter valued at approximately $214,000. 56.38% of the stock is currently owned by institutional investors and hedge funds.
Shares of USNA opened at $122.35 on Tuesday. USANA Health Sciences, Inc. has a 52 week low of $56.10 and a 52 week high of $137.95. The company has a market cap of $2.89 billion, a P/E ratio of 30.22 and a beta of 0.64.
Separately, Pivotal Research reaffirmed a “hold” rating and set a $135.00 price objective on shares of USANA Health Sciences in a research report on Wednesday, July 25th. One analyst has rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $135.00.
In other USANA Health Sciences news, insider Joshua Foukas sold 306 shares of the business’s stock in a transaction that occurred on Wednesday, September 12th. The shares were sold at an average price of $129.27, for a total value of $39,556.62. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Global Ltd Gull sold 12,436 shares of the business’s stock in a transaction that occurred on Saturday, December 1st. The stock was sold at an average price of $70.45, for a total transaction of $876,116.20. Following the completion of the sale, the insider now directly owns 10,921,009 shares of the company’s stock, valued at $769,385,084.05. The disclosure for this sale can be found here. Over the last three months, insiders acquired 19,117 shares of company stock valued at $1,349,965 and sold 994,500 shares valued at $127,469,281. Insiders own 48.00% of the company’s stock.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
See Also: Put Option
Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.